Journal article
Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of Gsα
Neuropsychopharmacology (New York, N.Y.), Vol.29(3), pp.494-501
03/2004
DOI: 10.1038/sj.npp.1300309
PMCID: PMC3348581
PMID: 14694347
Abstract
Schizophrenia is a complex disorder characterized by wide-ranging cognitive impairments, including deficits in learning as well as sensory gating. The causes of schizophrenia are unknown, but alterations in intracellular G-protein signaling pathways are among the molecular changes documented in patients with schizophrenia. Using the CaMKII
α
promoter to drive expression in neurons within the forebrain, we have developed transgenic mice that express a constitutively active form of G
s
α
(G
s
α
*), the G protein that couples receptors such as the D
1
and D
5
dopamine receptors to adenylyl cyclase. We have also generated mice in which the CaMKII
α
promoter drives expression of a dominant-negative form of protein kinase A, R(AB). Here, we examine startle responses and prepulse inhibition of the startle reflex (PPI) in these G
s
α
* and R(AB) transgenic mice. G
s
α
* transgenic mice exhibited selective deficits in PPI, without exhibiting alterations in the startle response, whereas no deficit in startle or PPI was found in the R(AB) transgenic mice. Thus, overstimulation of the cAMP/PKA pathway disrupts PPI, but the cAMP/PKA pathway may not be essential for sensorimotor gating. G
s
α
* transgenic mice may provide an animal model of certain endophenotypes of schizophrenia, because of the similarities between them and patients with schizophrenia in G-protein function, hippocampus-dependent learning, and sensorimotor gating.
Details
- Title: Subtitle
- Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of Gsα
- Creators
- Thomas J Gould - Department of Psychology, Temple University, Weiss Hall, Philadelphia, PA, USAScott P Bizily - Department of Biology, University of Pennsylvania, Philadelphia, PA, USAJan Tokarczyk - Division of Neuropsychiatry, University of Pennsylvania, Philadelphia, PA, USAMichele P Kelly - Department of Biology, University of Pennsylvania, Philadelphia, PA, USASteven J Siegel - Division of Neuropsychiatry, University of Pennsylvania, Philadelphia, PA, USAStephen J Kanes - Division of Neuropsychiatry, University of Pennsylvania, Philadelphia, PA, USATed Abel - Department of Biology, University of Pennsylvania, Philadelphia, PA, USA
- Resource Type
- Journal article
- Publication Details
- Neuropsychopharmacology (New York, N.Y.), Vol.29(3), pp.494-501
- DOI
- 10.1038/sj.npp.1300309
- PMID
- 14694347
- PMCID
- PMC3348581
- ISSN
- 0893-133X
- eISSN
- 1740-634X
- Grant note
- T32 MH019112-10 || MH / National Institute of Mental Health : NIMH R01 MH060244-02 || MH / National Institute of Mental Health : NIMH P50 MH064045-01 || MH / National Institute of Mental Health : NIMH
- Language
- English
- Date published
- 03/2004
- Academic Unit
- Molecular Physiology and Biophysics; Psychiatry; Psychological and Brain Sciences; Iowa Neuroscience Institute; Neuroscience and Pharmacology; Biochemistry and Molecular Biology
- Record Identifier
- 9984065739002771
Metrics
12 Record Views